Regeneron Fair Value
RE
The fair market value of REGN-RM.ME stock is 77255.28 RUB. Relative to the market price of 0 RUB Regeneron is overvalued by 4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Regeneron Valuation
The fair value level of 77255.28 RUB can be considered as an effective entry point for long-term investors to start investing in REGN-RM.ME stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Market price:
REGN-RM.ME stock is overvalued
It means the current price may concern as a Risky Entry Point
Regeneron Pharmaceuticals Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
24.55
2
Median P/E over 5 years
18.6
3
Minimum P/E over 5 years
9.57
4
Earning per share (last 12 months)
42.38 USD
Maximum value
1
x
4
=
101 937.84 RUB
Fair value
2
x
4
=
77 255.28 RUB
Minimum value
3
x
4
=
39 747.02 RUB
Regeneron Pharmaceuticals Inc price metrics
19.23
Annual return (geometric mean)
30.44
Risk (standard deviation) of returns
β
0.12
Beta (volatility compared to market)